Pap Smear News and Research

RSS

The Pap test, also called a Pap smear, checks for changes in the cells of your cervix. The cervix is the lower part of the uterus (womb) that opens into the vagina (birth canal). The Pap test can tell if you have an infection, abnormal (unhealthy) cervical cells, or cervical cancer.

Women who harbor multiple HPV type infections are at higher risk for cervical lesions

The risk for developing the tissue abnormalities, or lesions, that typically precede cervical cancer is much higher for women infected with multiple genotypes of the human papillomavirus (HPV) than previously reported.

10 Jul 2006

CDC recommends human papillomavirus virus vaccination

CDC Advisory Committee Recommends Human Papillomavirus Virus Vaccination Vaccine considered highly effective in preventing infections that are the cause of most cervical cancers.

29 Jun 2006

Vaccine no replacement for Pap test

The Cancer Council Australia cautioned that the vaccine was not a substitute for the Pap screen and that all women aged 18-69 should continue regular two year screening.

27 Jun 2006

PATH to pave the way for cervical cancer vaccines in the developing world

The global health nonprofit PATH has launched a five-year effort to make sure that new cervical cancer vaccines - the first vaccines developed and approved just for women's health - reach women in the developing world.

9 Jun 2006

How cow warts, clergy sex surveys moved along cervical cancer vaccine

The creation of a successful vaccine against cervical cancer, approved today by the U.S. Food and Drug Administration, is the culmination of research that occurred thanks not only to scientists and physicians, but also to generous farmers and veterinarians, priests and nuns willing to tell all - and some very patient cows.

9 Jun 2006

New era in cancer prevention

Nearly two decades ago, researchers at the National Cancer Institute (NCI) and other institutions began searching for the underlying causes of cervical cancer.

9 Jun 2006

FDA approves Gardasil as a treatment for cervical cancer

Merck & Co. has announced that the U.S. Food and Drug Administration (FDA) approved Gardasil as a treatment for cervical cancer, vulvar and vaginal pre-cancers caused by HPV types 16 and 18 and to prevent low-grade and pre-cancerous lesions and genital warts caused by HPV types 6, 11, 16 and 18.

9 Jun 2006

Human Papillomavirus testing and liquid-based cytology

Human papillomavirus (HPV) testing was more sensitive than traditional Pap smears at detecting precancerous lesions of the cervix, a study in the Journal of the National Cancer Institute reports.

7 Jun 2006

Bill Gates puts his money where his mouth is again

Once again Microsoft founder Bill Gates is putting his money where his mouth is and the world's poorest women will benefit.

6 Jun 2006

Combo of testing and vaccines a winner in fight against cervical cancer

According to experts in reproductive health, the combination of HPV testing with HPV vaccines is the best hope for preventing cervical cancer.

1 May 2006

Studies show HPV testing is more sensitive than current screening methods

The current technique for screening for cervical cancer involves collecting cells by way of a pap smear and examining them under a microscope. Although this method has reduced cervical cancer in countries where it is regularly used, it has several weaknesses.

3 Apr 2006

Human papillomavirus the main risk factor for cervical adenocarcinoma

Human papillomavirus (HPV) was found to be the main risk factor associated with increased incidence of an unusual type of cervical cancer called cervical adenocarcinoma, according to a study in the March 1 issue of the Journal of the National Cancer Institute.

1 Mar 2006

New system accurately predicts mortality of older Americans

Researchers at the San Francisco VA Medical Center have created an index that is 81 percent accurate in predicting the likelihood of death within four years for people 50 and older.

20 Feb 2006

Cost-effectiveness analysis of HPV testing

A new study has found that using human papillomavirus (HPV) DNA testing to determine who should receive a cervical examination called colposcopy is a cost-effective management strategy for women with equivocal Pap test results known as ASCUS (atypical squamous cells of undetermined significance).

18 Jan 2006